XHS vs. BBC
XHS (SPDR S&P Health Care Services ETF) and BBC (Virtus LifeSci Biotech Clinical Trials ETF) are both Health & Biotech Equities funds - XHS tracks the S&P Health Care Services Select Industry Index while BBC tracks the LifeSci Biotechnology Clinical Trials Index. Both are passively managed. Over the past 10 years, XHS returned 7.46%/yr vs 7.64%/yr for BBC. A 0.56 correlation means they provide meaningful diversification when combined. XHS charges 0.35%/yr vs 0.79%/yr for BBC.
Performance
XHS vs. BBC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XHS achieves a 6.32% return, which is significantly lower than BBC's 8.64% return. Both investments have delivered pretty close results over the past 10 years, with XHS having a 7.46% annualized return and BBC not far ahead at 7.64%.
XHS
- 1D
- 0.28%
- 1M
- 2.77%
- YTD
- 6.32%
- 6M
- 5.39%
- 1Y
- 16.58%
- 3Y*
- 8.47%
- 5Y*
- 0.44%
- 10Y*
- 7.46%
BBC
- 1D
- 0.43%
- 1M
- -6.52%
- YTD
- 8.64%
- 6M
- 14.08%
- 1Y
- 116.78%
- 3Y*
- 19.99%
- 5Y*
- -1.96%
- 10Y*
- 7.64%
XHS vs. BBC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XHS SPDR S&P Health Care Services ETF | 6.32% | 18.83% | 1.76% | 5.15% | -19.87% | 9.76% | 33.66% | 18.81% | 1.96% | 17.65% |
BBC Virtus LifeSci Biotech Clinical Trials ETF | 8.64% | 63.77% | -1.11% | -1.80% | -35.13% | -22.31% | 30.32% | 63.81% | -18.29% | 57.85% |
Correlation
The correlation between XHS and BBC is 0.35, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.35 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.46 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.57 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.56 |
Correlation (All Time) Calculated using the full available price history since Dec 18, 2014 | 0.56 |
Over the past year, the correlation between XHS and BBC has dropped to 0.35 - well below their long-term average of 0.56, suggesting their price drivers have been diverging.
XHS vs. BBC - Sectors Allocation Comparison
Sectors
XHS
BBC
Healthcare
Financial Services
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
XHS
BBC
Financial Services
XHS
BBC
-
Basic Materials
XHS
-
BBC
-
Communication Services
XHS
-
BBC
-
Consumer Cyclical
XHS
-
BBC
-
Consumer Defensive
XHS
-
BBC
-
Energy
XHS
-
BBC
-
Industrials
XHS
-
BBC
-
Real Estate
XHS
-
BBC
-
Technology
XHS
-
BBC
-
Utilities
XHS
-
BBC
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XHS vs. BBC — Risk / Return Rank
XHS
BBC
XHS vs. BBC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Health Care Services ETF (XHS) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XHS | BBC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.37 | ||
| Sortino ratioReturn per unit of downside risk | -2.58 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.46 | -0.29 |
| Calmar ratioReturn relative to maximum drawdown | 1.39 | 7.78 | -6.39 |
| Martin ratioReturn relative to average drawdown | 3.83 | 24.80 | -20.96 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XHS | BBC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.95 | 3.32 | -2.37 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.02 | -0.05 | +0.07 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.33 | 0.20 | +0.13 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.57 | 0.12 | +0.45 |
Drawdowns
XHS vs. BBC - Drawdown Comparison
The maximum XHS drawdown since its inception was -39.32%, smaller than the maximum BBC drawdown of -76.85%. Use the drawdown chart below to compare losses from any high point for XHS and BBC.
Loading charts...
Drawdown Indicators
| XHS | BBC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -39.32% | -76.85% | +37.53% |
Max Drawdown (1Y)Largest decline over 1 year | -11.99% | -15.10% | +3.11% |
Max Drawdown (3Y)Largest decline over 3 years | -17.81% | -54.45% | +36.64% |
Max Drawdown (5Y)Largest decline over 5 years | -32.62% | -72.44% | +39.82% |
Max Drawdown (10Y)Largest decline over 10 years | -39.32% | -76.85% | +37.53% |
Current DrawdownCurrent decline from peak | -1.78% | -30.27% | +28.49% |
Average DrawdownAverage peak-to-trough decline | -10.20% | -37.14% | +26.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.33% | 4.73% | -0.40% |
Volatility
XHS vs. BBC - Volatility Comparison
The current volatility for SPDR S&P Health Care Services ETF (XHS) is 4.80%, while Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a volatility of 10.93%. This indicates that XHS experiences smaller price fluctuations and is considered to be less risky than BBC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XHS | BBC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.80% | 10.93% | -6.13% |
Volatility (6M)Calculated over the trailing 6-month period | 11.86% | 26.43% | -14.57% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.56% | 35.50% | -17.94% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.10% | 39.31% | -18.21% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.40% | 37.74% | -15.34% |
XHS vs. BBC - Expense Ratio Comparison
XHS has a 0.35% expense ratio, which is lower than BBC's 0.79% expense ratio.
Dividends
XHS vs. BBC - Dividend Comparison
XHS's dividend yield for the trailing twelve months is around 0.25%, less than BBC's 1.56% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.56% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
XHS SPDR S&P Health Care Services ETF | 0.25% | 0.27% | 0.38% | 0.23% | 0.19% | 0.20% | 0.23% | 2.37% | 0.34% | 0.22% | 0.28% | 0.93% |
Frequently Asked Questions
XHS and BBC have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBC has higher volatility (10.93%) compared to XHS (4.80%). In terms of maximum drawdown, XHS dropped -39.32% vs BBC's -76.85%.
On 10-year performance, BBC leads with 7.64% vs 7.46% for XHS. On fees, XHS is cheaper at 0.35% per year. On volatility, XHS has been the lower-risk option at 4.80%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, BBC has performed better with a 7.64% return vs 7.46%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XHS is cheaper with a 0.35% expense ratio, compared with 0.79% for BBC.
BBC has the higher dividend yield at 1.56%, compared with 0.25% for XHS.
XHS tracks S&P Health Care Services Select Industry Index, while BBC tracks LifeSci Biotechnology Clinical Trials Index. They also come from different issuers: State Street and Virtus Investment Partners. Their fees differ too: 0.35% for XHS and 0.79% for BBC.
BBC currently has the higher Sharpe Ratio (3.32 vs 0.95), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XHS and BBC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer